Online First Nr277

Psychiatr. Pol. ONLINE FIRST Nr 277: 1–21

Published ahead of print 23 May 2022


Małgorzata Janas-Kozik, Dominika Dudek, Janusz Heitzman,
Barbara Remberk, Jerzy Samochowiec, Agnieszka Słopień, Adam Wichniak


Rekomendacje Polskiego Towarzystwa Psychiatrycznego w zakresie postępowania diagnostycznego i terapeutycznego u chorych ze schizofrenią o wczesnym początku


Polish Psychiatric Association diagnostic and therapeutic management guidelines for patients with early-onset schizophrenia
Early onset of schizophrenia (before the age of 18 years) is associated with a higher risk of delayed or missed diagnosis, more severe course of the disease, and an increased susceptibility to adverse reactions to antipsychotic drugs. The objective of this paper is to present the recommendations for the diagnostic and therapeutic management of patients with early-onset schizophrenia, developed on the basis of a literature review and a consensus of a group of experts working with schizophrenia therapy. The formal criteria that must be met to diagnose schizophrenia are the same for children and adults. Early-onset schizophrenia must be thoroughly differentiated from uni – or bipolar affective disorder, autism-spectrum disorders (ASDs) and anxiety disorder. Diagnostic assessment for psychotic disorders is also necessary in the case of abnormal, destructive or aggressive behaviour, or self-harm. The mainstay of schizophrenia treatment is pharmacological therapy, which is used in the treatment of acute episodes and in maintenance treatment – prevention of relapses. However, the use of pharmacological interventions in children and adolescents only to reduce the risk of psychosis development is not justified. Antipsychotic agents significantly differ by their tolerance profile and clinical efficacy. Second-generation antipsychotic agents approved for the treatment of early-onset schizophrenia – aripiprazole, lurasidone and paliperidone – enable its effective and safe treatment. The necessary complement to pharmacological therapy is non-pharmacological interventions that should be adapted to the patient’s age, cognitive abilities, disease stage and the needs of the whole family.


ISSN 0033-2674 (PRINT)

ISSN 2391-5854 (ONLINE)

Psychiatria Polska
is an Open Access journal:
Creative Commons: CC-BY

Zadanie finansowane
w ramach umowy
nr 739/P-DUN/2018
ze środków MNiSW
na działalność
upowszechniającą naukę

KRW PTP dziękuje 
firmie PPL – Koral – J.Koral sp.j.
za wsparcie finansowe 
udzielone w 2020 roku

Inne strony PTP:
Other PTP websites:

Psychiatria Polska
Thomson Reuters Master List
Science Citation Index Expanded
Journal Citation Reports
(Impact Factor 1,596)

Medline/Index Medicus
MNiSW (100 pkt)
CiteScore 2,4
(SJR 0,414; SNIP 0,707)
EMBASE/Excerpta Medica
Index Copernicus
Erih Plus, Cochrane Library

We recommend:

Pharmacological Reports


KONTAKT Z REDAKCJĄ - wyłącznie e-mail: 

Biuro KRW PTP - prenumeraty, faktury - wyłącznie e-mail: